InspireMD Reports Third Quarter 2025 Financial Results
InspireMD Reports Third Quarter 2025 Financial Results Successful initial CGuard Prime U.S. commercial launch drives record quarterly revenue GlobeNewswire November 04, 2025 MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard(R) Prime carotid stent system for the prevention of stroke, today announced financial and operating […]